FindTrial
Sign In

Is it safe and beneficial to use Bilateral internal mammary artery for revascularization of all three heart vessels

To estimate capacity of left internal mammary artery (LIMA) in situ as composite conduit with right internal mammary artery (LIMA) to provide sufficient blood flow to revascularize both left and right coronary system during coronary artery bypass grafting - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057964
Enrollment
100
Registered
2023-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dayanand Medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing coronary artery bypass grafting, using left internal mammary artery and right internal mammary artery as conduits.

Exclusion criteria

Exclusion criteria: • Left main disease • Akinetic, scarred territories, • Radiotherapy received • Ejection fraction less than 25%, • Redo CABG, • CABG associated with other procedure (valve repair or replacement), • • CABG associated with other Patients with single or double vessel disease, • Diffuse CAD disease, Emergency vascular operative interference (aortic root surgery) were excluded.

Design outcomes

Primary

MeasureTime frame
measurement of flows in the conduits using transit time flow meter( TTFM) measured as mean flow rate in milliliters per minute.Timepoint: At the completion of coronary artery anastomosis—

Secondary

MeasureTime frame
Incidence of stroke, incidence of Post op MITimepoint: till discharge from hospital—

Countries

India

Contacts

Public ContactVIKRAM PAL SINGH

Dayanand Medical college and hospital

vikramctvs@gmail.com01612304270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026